Acceptability of suction curettage and mifepristone abortion in the United States: A prospective comparison study

American Journal of Obstetrics and Gynecology

Volumn 182, Issue 6, 2000, Pages 1292-1299

  Jensen, Jeffrey T ^a   Harvey, S Marie ^b,c   Beckman, Linda J ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF OREGON   (United States)

^c Pacific Institute for Women's Health   (United States)

Author keywords

Abortion; Acceptability; Mifepristone; Misoprostol; Prospective; Suction curettage

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ABORTION; ADULT; COHORT ANALYSIS; CONFERENCE PAPER; EXPERIENCE; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PATIENT ATTITUDE; PREGNANCY TERMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SUCTION DRAINAGE; TREATMENT FAILURE;

EID: 0033919605     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.106183     Document Type: Article

References (18)

1. 1. Peyron R, Aubeny E, Targosz V, Silvestre L, Renault L. Early termination of pregnancy with mifepristone (RU486) and the orally active prostaglandin misoprostol. N Engl J Med 1993;328:1509-13.
2. 2. Silvestre L, Dubois C, Renault M, Rezvani Y, Baulieu EE, Ulmann A. Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue. N Engl J Med 1990;322:645-8
3. 3. Ulmann A, Silvestre L, Chemama L, Renault M, Aguillaume CJ, Baulieu EE. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women. Acta Obstet Gynecol Scand 1992;71:278-83.
4. 4. Norman JE, Thong KJ, Rodger MW, Baird DT. Medical abortion in women of less than or equal to 56 days amenorrhoea: a comparison between gemeprost (a PGEI analogue) alone and mifepristone and gemeprost. Br J Obstet Gynaecol 1992;99:601-6.
5. 5. Urquhart DR, Templeton AA, Shinewi F. The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK Multicentre Study -final results. Contraception 1997;55:1-5.
6. 6. Legarth J, Peen UB, Michelsen JW. Mifepristone or vacuum aspiration in termination of early pregnancy. Eur J Obstet Gynecol Reprod Biol 1991;41:91-6.
7. 7. Thong KJ, Dewar MH, Baird DT. What do women want during medical abortion? Contraception 1992;46:435-42.
8. 8. Holmgren K. Women's evaluation of three early abortion methods. Acta Obstet Gynecol Scand 1992;71:616-23.
9. 9. Urquhart DR, Templeton AA. Psychiatric morbidity and acceptability following medical and surgical methods of induced abortion. Br J Obstet Gynaecol 1991;98:396-9.
10. 10. Bachelot A, Cludy L, Spira A. Conditions for choosing between drug induced and surgical abortion. Contraception 1992;45:547-59.
11. 11. Winikoff B, Sivin I, Coyaji KJ, Cabezas E, Xiao B, Gu S, et al. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion. Am J Obstet Gynecol 1997;176:431-7.
12. 12. Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998;338:1241-7.
13. 13. Winikoff B, Ellertson C, Elul B, Sivin I. Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol. Results of a large multicenter trial in the United States. Arch Fam Med 1998;7:360-6.
14. 14. Jensen JT, Astley SJ, Morgan E, Nichols MD. Outcomes of suction curettage and mifepristone abortion in the United States: a prospective comparison study. Contraception 1999;59:153-9.
15. 15. Howie FL, Henshaw RC, Naji SA, Russell IT, Templeton AA. Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial. Br J Obstet Gynaecol 1997;104:829-33.
16. 16. Beckman LJ, Harvey SM. Experience and acceptability of medical abortion with mifepristone and misoprostol among US women. Womens Health Issues 1997;7:253-62.
17. 17. el-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995;332:983-7.
18. 18. Creiniu MD, Burke AE. Methotrexate and misoprostol for early abortion: a multicenter trial. Contraception 1996;54:19-22.